The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA; Novartis; UCB
Real-world (rw) treatment (tx) patterns, sequencing, and outcomes in US patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) treated with avelumab first-line maintenance (1LM).
 
Kenneth Robert Carson
Employment - Tempus
Leadership - Tempus
Stock and Other Ownership Interests - Tempus
Expert Testimony - Bayer
 
Chiemeka Ike
Employment - EMD Serono
Stock and Other Ownership Interests - Merck KGaA
 
Seyed Hamidreza Mahmoudpour
Employment - Merck KGaA
 
Sebastian Monzon
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Stamatina Fragkogianni
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Mairead Kearney
No Relationships to Disclose